Erlotinib might be a double-edged sword in HCC

Hepatology. 2015 Feb;61(2):729. doi: 10.1002/hep.27205. Epub 2014 Jul 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / prevention & control*
  • Disease Progression*
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • Liver Cirrhosis / prevention & control*
  • Liver Neoplasms / prevention & control*
  • Male
  • Quinazolines / therapeutic use*

Substances

  • Quinazolines
  • ErbB Receptors